Nektar Therapeutics (NKTR)
1.76
+0.16
(+10.00%)
USD |
NASDAQ |
May 10, 16:00
1.79
+0.03
(+1.70%)
After-Hours: 20:00
Nektar Therapeutics Gross Profit (Quarterly): 16.60M for Dec. 31, 2023
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 16.60M |
September 30, 2023 | 11.71M |
June 30, 2023 | 13.50M |
March 31, 2023 | 14.53M |
December 31, 2022 | 15.79M |
September 30, 2022 | 18.65M |
June 30, 2022 | 16.47M |
March 31, 2022 | 19.51M |
December 31, 2021 | 18.85M |
September 30, 2021 | 19.61M |
June 30, 2021 | 20.66M |
March 31, 2021 | 17.89M |
December 31, 2020 | 19.14M |
September 30, 2020 | 24.46M |
June 30, 2020 | 43.07M |
March 31, 2020 | 46.76M |
December 31, 2019 | 27.87M |
September 30, 2019 | 24.29M |
June 30, 2019 | 18.30M |
March 31, 2019 | 22.78M |
December 31, 2018 | 32.36M |
September 30, 2018 | 22.98M |
June 30, 2018 | 1.082B |
March 31, 2018 | 31.37M |
December 31, 2017 | 85.71M |
Date | Value |
---|---|
September 30, 2017 | 147.25M |
June 30, 2017 | 25.60M |
March 31, 2017 | 18.60M |
December 31, 2016 | 30.85M |
September 30, 2016 | 29.30M |
June 30, 2016 | 25.06M |
March 31, 2016 | 50.01M |
December 31, 2015 | 31.01M |
September 30, 2015 | 53.19M |
June 30, 2015 | 12.13M |
March 31, 2015 | 100.36M |
December 31, 2014 | 13.25M |
September 30, 2014 | 123.65M |
June 30, 2014 | 23.40M |
March 31, 2014 | 11.86M |
December 31, 2013 | 22.19M |
September 30, 2013 | 48.03M |
June 30, 2013 | 28.85M |
March 31, 2013 | 11.34M |
December 31, 2012 | 13.86M |
September 30, 2012 | 11.18M |
June 30, 2012 | 16.48M |
March 31, 2012 | 9.242M |
December 31, 2011 | 10.33M |
September 30, 2011 | 22.03M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
11.71M
Minimum
Sep 2023
46.76M
Maximum
Mar 2020
21.46M
Average
18.85M
Median
Dec 2021
Gross Profit (Quarterly) Benchmarks
Stereotaxis Inc | 2.738M |
Vanda Pharmaceuticals Inc | 41.81M |
Cara Therapeutics Inc | 2.396M |
Avid Bioservices Inc | 2.383M |
Rigel Pharmaceuticals Inc | 32.00M |